Historical record - last NADAC effective date: 8/21/2019
Product Information
FIRVANQ 25 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $0.6636 per ML under NDC 65628020405. Its NADAC has been published 52 times since Aug 21, 2019.
FDA first approved this application on Jan 26, 2018. Its Orange Book therapeutic-equivalence code is AA.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628020405
Classification
Brand
Dosage Form
KIT
Effective Date
8/21/2019
Approval Type
New Drug (NDA)
FDA Application
NDA208910FDA Approved
1/26/2018
TE Code
AA
On Market Since
1/26/2018
Price Statistics
The NADAC for FIRVANQ 25 MG/ML SOLUTION has been published 52 times since Aug 21, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6636 per ML |
|---|---|
| All-time high | $0.6636 (Aug 12, 2020) |
| All-time low | $0.6636 (Aug 21, 2019) |
| Median price | $0.6636 |
| Average price | $0.6636 |
| Largest weekly change | 0.0% (Aug 28, 2019) |
| Weeks tracked | 52 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Aug 12, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Azurity Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vancomycin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FIRVANQ 25 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FIRVANQ 25 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $0.6636 per ML (NDC 65628020405), effective Aug 12, 2020.
How has the price of FIRVANQ 25 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FIRVANQ 25 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for FIRVANQ 25 MG/ML SOLUTION?
Since Aug 21, 2019, the NADAC for FIRVANQ 25 MG/ML SOLUTION has ranged from a low of $0.6636 (Aug 21, 2019) to a high of $0.6636 (Aug 12, 2020), with a median of $0.6636 per ML.
Are there cheaper alternatives to FIRVANQ 25 MG/ML SOLUTION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VANCOMYCIN 25 MG/ML ORAL SOLN, is $0.3900 per ML — about 41% below FIRVANQ 25 MG/ML SOLUTION.
Who manufactures FIRVANQ 25 MG/ML SOLUTION?
FIRVANQ 25 MG/ML SOLUTION (NDC 65628020405) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.